Profile data is unavailable for this security.
About the company
Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
- Revenue in EUR (TTM)256.91m
- Net income in EUR15.65m
- Incorporated2018
- Employees1.42k
- LocationStratec SeGewerbestr. 37BIRKENFELD 75217GermanyDEU
- Phone+49 708279160
- Fax+49 70 827916999
- Websitehttps://www.stratec.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nordhealth As | 50.26m | -10.65m | 136.47m | 450.00 | -- | 3.66 | -- | 2.72 | -1.52 | -1.52 | 7.18 | 9.32 | 0.6188 | -- | 8.10 | 1,381,440.00 | -13.11 | -- | -14.99 | -- | 82.95 | -- | -21.19 | -- | -- | -- | 0.00 | -- | 24.03 | -- | 31.06 | -- | -- | -- |
| Oncosem Onkolojik Sistemlr Sny v Tcrt AS | 11.27m | 287.16k | 140.83m | 358.00 | 490.41 | 19.90 | 101.89 | 12.49 | 0.624 | 0.624 | 24.49 | 15.37 | 1.26 | 4.61 | 4.26 | 2,000,638.00 | 3.20 | -7.80 | 4.30 | -10.68 | 36.39 | 33.56 | 2.55 | -8.41 | 1.86 | 3.04 | 0.1562 | -- | 7.85 | 50.94 | 48.65 | -- | 10.14 | -- |
| Stille AB | 53.41m | 5.24m | 155.98m | 220.00 | 29.73 | 2.34 | 18.59 | 2.92 | 6.21 | 6.21 | 63.80 | 78.87 | 0.5523 | 1.71 | 6.91 | 2,580,132.00 | 5.42 | 6.00 | 6.18 | 6.84 | 50.73 | 48.81 | 9.81 | 9.86 | 1.95 | -- | -- | -- | -0.4072 | 31.82 | -4.31 | 46.43 | -2.68 | -- |
| Carasent AB (publ) | 32.35m | 3.26m | 159.91m | 196.00 | 47.00 | 1.99 | 17.24 | 4.94 | 0.50 | 0.50 | 4.85 | 11.80 | 0.3416 | -- | 7.94 | 1,754,184.00 | 3.44 | -- | 3.89 | -- | 84.06 | -- | 10.08 | -- | -- | -- | 0.038 | -- | 24.91 | -- | 182.04 | -- | -- | -- |
| Nyxoah SA | 5.64m | -83.72m | 162.21m | 184.00 | -- | 2.78 | -- | 28.77 | -2.24 | -2.24 | 0.1509 | 1.36 | 0.0477 | 0.3543 | 2.15 | 30,646.74 | -70.84 | -27.03 | -83.81 | -29.81 | 64.36 | 63.56 | -1,484.66 | -1,347.97 | 1.41 | -- | 0.2934 | -- | 3.98 | -- | -37.08 | -- | 86.96 | -- |
| Detection Technology Oyj | -100.00bn | -100.00bn | 162.68m | 497.00 | -- | 2.08 | -- | -- | -- | -- | -- | 5.34 | -- | -- | -- | -- | -- | 8.02 | -- | 10.04 | -- | 46.64 | -- | 7.50 | 2.30 | -- | -- | 61.79 | -6.04 | 4.37 | -42.04 | -0.892 | -13.11 | 1.39 |
| Guerbet SA | 809.67m | 7.74m | 173.18m | 2.91k | 33.71 | 0.459 | 2.46 | 0.2139 | 0.4064 | 0.4064 | 64.25 | 29.85 | 0.7865 | 0.546 | 4.90 | 278,715.70 | 0.4619 | 0.92 | 0.6055 | 1.20 | 78.03 | 76.51 | 0.5873 | 1.19 | 1.03 | 1.46 | 0.5172 | 64.79 | 7.05 | 0.5853 | -32.61 | -15.50 | -0.8569 | -- |
| Median Technologies SA | 23.31m | -21.99m | 183.96m | 211.00 | -- | -- | -- | 7.89 | -1.16 | -1.16 | 1.23 | -2.08 | 0.8894 | -12.98 | 3.92 | 96,717.84 | -83.91 | -60.70 | -- | -232.35 | 102.73 | 102.32 | -94.35 | -97.73 | 0.3543 | -26.56 | -- | -- | 3.25 | 20.72 | -9.83 | -- | 43.77 | -- |
| Prim SA | 240.47m | 14.55m | 216.36m | 954.00 | 13.84 | 1.63 | 8.48 | 0.8998 | 0.9176 | 0.9176 | 14.13 | 7.80 | 1.17 | 1.97 | 4.17 | 251,008.80 | 7.09 | 6.27 | 10.40 | 8.50 | 38.77 | 37.70 | 6.05 | 5.85 | 1.20 | 144.87 | 0.1399 | 63.10 | 7.68 | 9.08 | -13.83 | -0.5366 | 13.50 | 6.35 |
| Tristel Plc | 53.18m | 7.60m | 226.26m | 265.00 | 29.83 | 5.97 | 20.94 | 4.25 | 0.1383 | 0.1383 | 0.9676 | 0.6915 | 1.04 | 1.93 | 5.81 | 175,328.30 | 14.85 | 9.60 | 17.57 | 11.09 | 80.62 | 80.90 | 14.29 | 11.04 | 2.96 | -- | 0.1512 | 120.71 | 10.80 | 7.96 | 2.33 | 5.42 | -3.59 | 18.10 |
| Onward Medical NV | 1.11m | -38.65m | 231.32m | 102.00 | -- | 6.65 | -- | 208.02 | -0.866 | -0.866 | 0.0249 | 0.6209 | 0.0215 | -- | 9.11 | 10,901.96 | -74.86 | -55.03 | -92.84 | -61.19 | 77.16 | -- | -3,475.81 | -39,652.37 | 4.30 | -17.13 | 0.352 | -- | 236.76 | -- | 1.26 | -- | 3.88 | -- |
| Affluent Medical SAS | 4.12m | -14.74m | 235.20m | 76.00 | -- | 7.40 | -- | 57.11 | -0.3759 | -0.3759 | 0.1051 | 0.5365 | 0.0709 | -- | 0.9541 | 59,681.16 | -25.40 | -23.76 | -32.61 | -27.59 | 1.34 | -226.93 | -358.01 | -1,815.40 | -- | -924.30 | 0.5030 | -- | -- | -- | 5.84 | -- | -- | -- |
| Stratec SE | 256.91m | 15.65m | 254.10m | 1.42k | 16.23 | 1.06 | 7.37 | 0.9891 | 1.29 | 1.29 | 21.13 | 19.75 | 0.5825 | 1.32 | 5.65 | 177,177.20 | 3.55 | 6.72 | 4.24 | 7.96 | 29.09 | 28.41 | 6.09 | 9.63 | 1.65 | 6.85 | 0.3552 | 37.35 | -4.73 | 3.76 | 4.24 | 2.35 | -7.49 | -6.51 |
| Medistim ASA | 59.19m | 12.61m | 305.18m | 154.00 | 24.14 | 8.21 | 20.40 | 5.16 | 7.79 | 7.79 | 36.56 | 22.91 | 1.25 | 0.7679 | 9.67 | 4,341,637.00 | 26.72 | 21.98 | 33.09 | 27.19 | 81.21 | 78.66 | 21.30 | 20.32 | 2.03 | -- | 0.0484 | 85.04 | 6.88 | 9.12 | 0.0087 | 8.11 | 12.53 | 16.89 |
| CellaVision AB | 71.41m | 14.40m | 335.27m | 236.00 | 23.28 | 4.01 | 18.52 | 4.70 | 6.42 | 6.42 | 31.82 | 37.21 | 0.7201 | 2.02 | 6.80 | -- | 14.52 | 14.71 | 16.22 | 16.96 | 68.50 | 68.38 | 20.17 | 19.85 | 2.97 | 25.88 | 0.0281 | 41.97 | 4.94 | 9.99 | 8.78 | 11.34 | 20.76 | 29.67 |
Data as of Feb 18 2026. Currency figures normalised to Stratec Se's reporting currency: Euro EUR
27.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brown Capital Management LLCas of 30 Sep 2025 | 1.09m | 8.99% |
| Union Investment Privatfonds GmbHas of 27 Mar 2025 | 464.95k | 3.82% |
| Juno Investment Partners BVas of 30 Sep 2025 | 418.59k | 3.44% |
| Janus Henderson Investors UK Ltd.as of 31 Dec 2025 | 304.67k | 2.51% |
| Candriam Belgium SAas of 31 Dec 2025 | 183.82k | 1.51% |
| Invesco Advisers, Inc.as of 22 Jan 2025 | 180.57k | 1.49% |
| UBS Asset Management Switzerland AGas of 31 Oct 2025 | 180.00k | 1.48% |
| Financi�re de l'�chiquier SAas of 30 Sep 2024 | 164.44k | 1.35% |
| BNP Paribas Asset Management Europe SASas of 30 Jan 2026 | 159.29k | 1.31% |
| Investor Asset Management BVas of 06 Feb 2026 | 139.50k | 1.15% |
More ▼
Data from 30 Sep 2025 - 06 Feb 2026Source: FactSet Research Systems Inc.
